Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • P vs GSK✓SelectedUSD · GSKP vs GSK performance historyLatest closeAs of-3.99%11/16
Stock and ETF performance explorer

P vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+620.0%
GSK return
+107.3%
Excess return
+512.7%
Maximum drawdown
-69.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-3.9%-4.0%
7D+0.8%-1.3%+2.1%+1.1%
30D-16.4%+2.7%-19.1%-16.9%
3M-12.3%+2.7%-15.0%-13.0%
6M+27.7%+3.3%+24.4%+25.4%
YTD+54.7%+6.5%+48.3%+49.8%
1Y+22.6%+10.7%+11.9%+17.1%
3Y+186.7%+64.4%+122.4%+130.6%
5Y+268.6%+46.7%+221.9%+203.6%
10Y+620.0%+109.4%+510.6%+382.0%
All+620.0%+107.3%+512.7%+382.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling